Germany - The Translational science building for CARDiovascular research in DIABetes (CARDDIAB) is intended to enable successful translational research at the important interface of cardiovascular diseases and diabetes at the Düsseldorf hospital site ...
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 24 April 2024
- Opportunity publication date
- 26 March 2024
- Value of contract
- to be confirmed
- Your guide to exporting
Description
The Translational science building for CARDiovascular research in DIABetes (CARDDIAB) is intended to enable successful translational research at the important interface of cardiovascular diseases and diabetes at the Düsseldorf hospital site. The aim is to create an architecture in which functionally complex requirements offer a positive environment for employees and test subjects with a high quality of stay through clear design.
- Opportunity closing date
- 24 April 2024
- Value of contract
- to be confirmed
About the buyer
- Address
- Universitätsklinikum Düsseldorf Moorenstr. 5 40225 GERMANY
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.